New medical technologies in a cost containment environment: Implantable antitachyarrhythmia devices.
D014487:Centers for Medicare and Medicaid Services, U.S.; D003363:Cost Control; D003362:Cost-Benefit Analysis; D004059:Diffusion of Innovation; D006297:Health Services Accessibility; D006801:Humans; D007349:Insurance, Health, Reimbursement; D013677:Medical Laboratory Science / Q000191:economics / Q000295:instrumentation*; D010138:Pacemaker, Artificial / Q000191:economics*; D011785:Quality Assurance, Health Care; D013610:Tachycardia / Q000628:therapy*; D014481:United States; D014486:United States Food and Drug Administration